A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma
一项评估双重 mTORC1/2 和 PI3K 抑制剂 Bimiralisib (PQR309) 在复发难治性淋巴瘤中安全性和有效性的 II 期研究
期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000656
Collins, Graham P; Eyre, Toby A; Schmitz-Rohmer, Debora; Townsend, William; Popat, Rakesh; Giulino-Roth, Lisa; Fields, Paul A; Krasniqi, Fatime; Soussain, Carole; Stathis, Anastasios; Andjelkovic, Nebojsa; Cunningham, David; Mandic, Danijela; Radulovic, Sinisa; Tijanic, Ivan; Horowitz, Netanel A; Kurtovic, Sabira; Schorb, Elisabeth; Schmidt, Christian; Dimitrijević, Saša; Dreyling, Martin
